![Obadiah J. Plante](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Obadiah J. Plante
Keine laufenden Positionen mehr
Profil
Dr. Obadiah J.
Plante is Senior Director-Discovery Research at Synglyco, Inc.
He received his undergraduate degree from Worcester Polytechnic Institute, a graduate degree from Columbia University, and a doctorate degree from the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Obadiah J. Plante
Unternehmen | Position | Ende |
---|---|---|
Synglyco, Inc.
![]() Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | Gründer | - |
Ausbildung von Obadiah J. Plante
Worcester Polytechnic Institute | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Synglyco, Inc.
![]() Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | Health Technology |